Company: SHPH
Filing Date: 2025-01-24
Form Type: 424B3
Source: 0001493152-25-003508
Chunk: 58

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-01-24
Form: 424B3
Chunk 58
---
 as well as Delaware law, might discourage, delay or prevent a change of control of our company or changes in our management and, therefore, depress the market price of our common stock.

Our Certificate of Incorporation and Bylaws, each as amended to date, and bylaws contain provisions that could depress the market price of our common stock by acting to discourage, delay, or prevent a change in control of our company or changes in our management that the stockholders of our company may deem advantageous. These provisions, among other things:

| ● | permit                                                                                                           
 the board of directors to establish the number of directors;                                                     |
| ● | provide                                                                                                          
 that directors may only be removed “for cause” and only with the approval of 66 2/3 percent of our stockholders; |

| ● | require                                                                                                                            
 super-majority voting to amend some provisions in our Certificate of Incorporation and Bylaws;                                     |
| ● | authorize                                                                                                                          
 the issuance of “blank check” preferred stock that our board of directors could use to implement a stockholder rights              
 plan (also known as a “poison pill”);                                                                                              |
| ● | eliminate                                                                                                                          
 the ability of our stockholders to call special meetings of stockholders;                                                          |
| ● | prohibit                                                                                                                           
 stockholder action by written consent, which requires all stockholder actions to be taken at a meeting of our stockholders;        |
| ● | provide                                                                                                                            
 that the board of directors is expressly authorized to make, alter or repeal our bylaws; and                                       |
| ● | establish                                                                                                                          
 advance notice requirements for nominations for election to our board of directors or for proposing matters that can be acted upon 
 by stockholders at annual stockholder meetings.                                                                                    |

| 40 |

In addition, Section 203 of the Delaware General Corporation Law may discourage, delay or prevent a change in control of our company. Section 203 imposes certain restrictions on merger, business combinations and other transactions between us and holders of 15% or more of our common stock.

The restatement of our consolidated financial statements and identification of material weaknesses in our internal controls may result in additional risks and uncertainties, including regulatory, stockholder or other actions, loss of investor and counterparty confidence and negative impacts on our stock price.

On July 10, 2024, the Audit Committee and Company management, after consultation and discussion with our independent registered public accounting firm, concluded that certain of our previously issued audited consolidated financial statements and unaudited consolidated financial